Linzess 72 MCG capsule UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9GM7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,244
Award facts
- Contract value 100% obligated
- $27,244.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $27,244.31 to AmerisourceBergen Drug Corp for the supply of Linzess 72 MCG capsules (30-count units) with a firm fixed price structure. This non-set-aside contract was competitively awarded on December 18, 2025, with an ultimate completion date of December 19, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, will fulfill this pharmaceutical supply requirement supporting military and defense healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive global pharmaceutical support vehicle valued through December 2026. The parent contract serves as a flexible procurement mechanism enabling the company to supply a broad range of pharmaceutical products, medical devices, and healthcare commodities to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The competitive delivery order structure demonstrates the company's established capability to meet federal pharmaceutical procurement requirements within the DLA's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F9GM7?
SPE2DR26F9GM7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26F9GM7 worth?
The government has obligated $27,244 on SPE2DR26F9GM7.
Is contract SPE2DR26F9GM7 an order under another contract?
Yes. SPE2DR26F9GM7 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9GM7 competed?
The extent of competition for SPE2DR26F9GM7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award